Clinical Trial for Lupus
For decades, lupus has been a challenging disease with little clinical progress. An investigational drug called Benlysta claims to offer hope for patients with systemic lupus erythematosus, if approved. With successful pivotal Phase 3 trials, University of Miami Miller School of Medicine expert Carlos Lozada, M.D., associate professor of clinical medicine, discusses the strengths and limitations of the trials and possible safety concerns. He is joined by Stacy Ardoin, M.D., assistant professor of clinical immunology and rheumatology at Ohio State University College of medicine.